CrowdStrike Holdings, Inc. – Consensus Indicates Potential 35.1% Upside

DirectorsTalk Interviews

CrowdStrike Holdings, Inc. found using ticker (CRWD) have now 32 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 385 and 193 calculating the average target price we see 242.94. Given that the stocks previous close was at 179.88 this would indicate that there is a potential upside of 35.1%. The 50 day MA is 186.04 and the 200 day moving average is 187.77. The company has a market cap of $44,293m. Visit the company website at: https://www.crowdstrike.com

The potential market cap would be $59,821m based on the market concensus.

CrowdStrike Holdings, Inc. provides cloud-delivered protection across endpoints and cloud workloads, identity, and data. It offers threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. The company primarily sells subscriptions to its Falcon platform and cloud modules through its direct sales team that leverages its network of channel partners. It serves customers worldwide. The company was incorporated in 2011 and is based in Austin, Texas.

Share on:

Latest Company News

Ilika plc Advances Solid-State Batteries With 10Ah Goliath Breakthrough (Video)

Ilika plc has shipped its 10Ah Goliath solid-state battery prototypes, marking a major scale-up from earlier designs. CEO Graeme Purdy outlines how higher-energy materials and an automated pilot line delivered a 93% yield, signalling readiness for larger-scale manufacturing.

Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production

Harbour Energy has agreed to acquire most subsidiaries of Waldorf Energy Partners and Waldorf Production for $170 million, a move expected to add 20 kboepd of oil weighted production and 35 mmboe of 2P reserves.

TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs

TwentyFour Income Fund noted improved market sentiment in November, supported by progress in Ukraine peace discussions and a stable UK Budget response.

GSK RSV vaccine recommended for wider adult use, CHMP backs expansion

GSK has announced that the EMA’s CHMP has recommended broadening the indication of its adjuvanted RSV vaccine to adults aged 18 and over, with a final decision expected in February 2026.

UK equities regain investor interest as valuation opportunities widen

Fidelity Special Values manager Alex Wright says UK equities have seen renewed interest as valuations remain attractive compared with global peers. The trust continues to follow a contrarian approach, focusing on undervalued mid and small cap companies and aiming to identify positive change not yet reflected in share prices.

Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT)

As at the end of October 2025, Global Opportunities Trust continued to apply its value focused strategy across global markets, holding a blend of equities, private market investments and significant liquidity positions.

    Search

    Search